Health Economic Modelling
Health Economic Modelling
We think outside the box and deliver creative solutions to demonstrate value
HEOR has an established reputation for innovative modelling approaches and technical excellence. Our models are intuitive, scientifically robust and clinically appropriate
We have deep expertise across all model types, our researchers are members of the ISPOR-SMDM Joint Modelling Good Research Practices Task Force and have been active participants in the Mount Hood diabetes modelling challenges
We translate complex problems clearly and transparently, to deliver models that are user-friendly and fit for purpose. Our experience spans pharmaceuticals, diagnostics, devices, and healthcare service delivery, across a wide variety of disease areas
Cost-effectiveness models
HEOR have extensive experience in the design and development of transparent, user-friendly global cost-effectiveness models and local country adaptations
Our models are often used to support health technology assessments across the globe. We have recently supported health technology assessments in the United Kingdom, France, Canada, Australia, Netherlands, Belgium, Sweden, Norway, Italy, Spain, Portugal, Switzerland, Greece, Poland, Austria and Eastern Europe, Latin America and Asia
Budget impact models
Our robust budget impact models adhere to recommended best-practice guidelines as well as being transparent and relevant in demonstrating the financial consequences associated with the uptake of a new product
Disease and natural history models
Modelling the natural history of disease (progression in the absence of intervention) and the impact of therapeutic interventions is a core research activity for HEOR. Our experience and expertise encompasses Markov models, individual patient-level simulation models (fixed-time increment or discrete event simulation) and disease transmission models
Model conceptualisation is a key part of our model development process as we believe that a ‘one size fits all’ approach can miss opportunities to capture key areas of treatment benefit
Health Economic
Model strategy and design
Model testing and validation
Cost-effectiveness models
- Early
- Global
- HTA
Budget impact models
Pricing models
Disease and natural history models
- Markov
- Individual patient-level simulation
- Disease transmission
